Results From the New Jersey Statewide Critical Congenital Heart Defects Screening Program
Lorraine F. Garg(New Jersey Department of Health), Alex R. Kemper(Nationwide Children's Hospital), Mary M. Knapp(New Jersey Department of Health), Leslie M. Beres(New Jersey Department of Health), Daniel Hirsch(Johnson University), Robert Koppel(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Joseph Sweatlock(National Center for Environmental Health), Jill Glidewell(Centers for Disease Control and Prevention), Richard S. Olney(University of Iowa), Cynthia F. Hinton(Centers for Disease Control and Prevention), Terry M. Anderson(Children's Hospital of Philadelphia), Kim Van Naarden Braun(Centers for Disease Control and Prevention)
Cited by 75
Related Papers
Guidelines for case classification for the national birth defects prevention study
|Birth Defects Research Part A Clinical and Molecular Teratology|2003|582
Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
|American Journal of Epidemiology|2000|535
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
|New England Journal of Medicine|2007|501
Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
|PEDIATRICS|2022|496
Pulse oximetry: fundamentals and technology update
|Medical Devices Evidence and Research|2014|422